Source: Google Images
I am fascinated with commodities. This is why I invest in companies like Cal-Maine Foods (CALM), Sanderson Farms (SAFM), Bunge Limited (BG), Hormel Foods (HRL), Fresh Del Monte (FDP), and oh yea, Concho Resources (CXO), Pioneer Natural Resources (PXD) and Rice Midstream Partners (RMP).
But it is very important to follow indicators impacting companies with exposure to commodities. For companies like Cal-Maine, Hormel and Sanderson, this relates to their produced products, as well as their cost inputs. Others may be more sensitive to core produced supply and demand trends.
stock investor: Education Realty Trust Inc.(EDR)
- [By ]
Education Realty Trust (NYSE: EDR) is a U.S.-based REIT that specializes in owning and managing collegiate housing facilities near universities. With a market cap of $2.8 billion, this is also one of the larger REITs in the United States. EDR made four dividend payments in 2017 totaling $1.54. That gives shares a current yield of 4.3%, more than a 100% premium to the S&P 500’s 2.0%. EDR also has an impressive history of dividend hikes. Since bottoming out at $0.15 in 2008 after the financial crisis, EDR’s dividend payment has jumped 160%.
stock investor: Helen of Troy Limited(HELE)
- [By Teresa Rivas]
Helen of Troy (HELE) is trading lower Friday, after reporting a mixed first quarter.
The personal care products company said it earned $1.27 a share on revenue that rose 0.8% to $347.9 million. Analysts were expecting earnings of $1.17 per share on revenue of $356.1 million. Gross profit margin increased 2.3 percentage points to 43.8%, while cash flow from operations climbed from $37.8 million in the year ago period to $41.7 million.
For the full year, Helen of Troy expects to earn between $5.85 to $6.35 a share on revenue of $1.57 billion to $1.62 billion. Analysts are modeling for earnings of $6.12 a share on revenue of $1.6 billion. However the company also warned that it expects a decline in sales for its nutritional supplement division.
Jefferies Trevor Young reiterated a Buy rating and $114 price target on the stock today:
Despite the 1Q revenue miss and ~30bps (~$4m) expected incremental FX headwinds, management maintained its FY revenue and adjusted EPS guidance (GAAP EPS came down $0.23 on the high and low end due to $6.6m of after tax non-cash asset impairment and patent litigation charges). Embedded in this guidance is the assumption of beauty coming in at the low end of the previous -7% to -12% range, and nutritional declining MSD (vs. flat to LSD positive growth previously). We believe this implies that housewares (MSD positive growth guidance previously) and health & home (LSD positive growth previously) would have to perform incrementally better than prior expectations, which we view as a positive.
The shares are down 3.3% to $99.31 in recent trading.
stock investor: (PAT)
- [By Sara Cornell]
With a growing need for global security both on the national defense front as well as in the cyber security arena, Patriot One Technologies Inc., (TSX.V: PAT) (OTCQB: PTOTF) is taking advantage of increasing security demands by entering into an agreement with a strategic industry partner in order to significantly broaden its product and commercialization offerings.
- [By Elizabeth Loring]
Last week Patriot One Technologies (OTCQB: PTOTF) (TSX VENTURE: PAT), the Toronto, Ontario based company that aims to limit the spread of active violence through superior detection technology by instantly identifying concealed weapons, even on moving targets. announced the appointment of Mr. John Gillies as a member of it’s Board of Directors.
- [By Sara Cornell]
In a move that should resonate well with investors, Patriot One Technologies (OTCQB: PTOTF) (TSX-V: PAT) today announced a reseller agreement with JJB Federal LLC and its specialty sales division UnitedEye Inc. Patriot One Technologies has developed PATSCAN, a first-of-its-kind concealed weapons detection system to combat active shooter threats before they occur. The agreement should help Patriot One distribute and install its concealed weapons detection system in strategic locations much faster and with greater efficiency, ultimately providing enhanced protection to citizens across the globe.
stock investor: Theravance Biopharma, Inc.(TBPH)
- [By WWW.KIPLINGER.COM]
The exact date Theravance Biopharma Inc. (TBPH) intends to release a phase 3 update on COPD treatment Revefenacin isnt known. The company simply said in a prior communication with the market it would be sharing an interim look at the trials progress sometime in early Q4.
stock investor: Sigma Designs, Inc.(SIGM)
- [By Lisa Levin]
Sigma Designs Inc (NASDAQ: SIGM) shares dropped 30 percent to $5.43. Sigma Designs reported fiscal third-quarter net income of $221,000 on revenue of $62.7 million.
- [By Paul Ausick]
Sigma Designs Inc. (NASDAQ: SIGM) dropped about 34% on Wednesday to post a new 52-week low of $5.20 against a 52-week high of $8.60 and a Tuesday close of $7.75. Volume of about 6.2 million was about 25 times the daily average of around 280,000. The company reported so-so earnings on Tuesday and the stock was downgraded and price targets lowered by several analysts.
- [By Lisa Levin]
Pyxis Tankers Inc. (NYSE: PXS) rose 47.48 percent to $$5.56, after the company announced it has entered into a definitive securities purchase agreement with a group of investors, which will result in gross proceeds of $4.8 million.
Sigma Designs Inc (NASDAQ: SIGM) rose 22.77 percent to $6.88. Silicon Laboratories (NASDAQ: SLAB) announced plans to buy Sigma Designs for $7.05 per share in cash.
Steadymed Ltd (NASDAQ: STDY) rose 19.35 percent to $3.70, after the company reported that no clinical trials were required for Trevyent and that the FDA had agreed to the pathway for the drug candidate's NDA resubmission.
Iteris, Inc. (NASDAQ: ITI) rose 15.73 percent to $7.06. Earlier in the week, Zacks Investment Research had upgraded the company from "Sell" to "Hold".
Science Applications International Corp (NYSE: SAIC) rose 13.71 percent to $85.77 as the company reported better-than-expected earnings for its third quarter.
Technical Communications Corporation (NASDAQ: TCCO) rose 12.41 percent to $6.07, after having risen sharply in pre-marketing trading.
Radius Health, Inc. (NASDAQ: RDUS) rose 12.41 percent to $30.81 after the company provided an update on data from the Phase 1 005 clinical study of elacestrant in patients with estrogen receptor positive breast cancer during the 2017 San Antonio Breast Cancer Symposium.
ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 12.32 percent to $25.80 after the company reported its third quarter financial results.
Prana Biotechnology Limited (NASDAQ: PRAN) rose 11.36 percent to $3.43, as the company announced a research collaboration with Takeda Pharmaceuticals to study the ability of movement disorders compound, PBT434 to slow or prevent neurodegeneration of the gastrointestinal system.
Catalyst Biosciences, Inc. (NASDAQ: CBIO) rose 10.49 percent to $7.90 as the company announced the appointment of Arwa Shurrab and Jamie Ellen Siegel in its clinical hemophilia